Geospiza, OpGen Win $100K SBIR for Optical Mapping Sequence Assembly | GenomeWeb

NEW YORK, July 27 (GenomeWeb News) - Geospiza and OpGen have secured a six-month, $100,000 Phase I Small Business Innovative Research grant from the National Institutes of Health to co-develop genomic sequencing tools based on optical mapping technology, the companies said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.